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MEASURING SKELETAL MUSCLE oxidative metabolism has been important in understanding muscle function in health and disease (19, 23) . Noninvasive methodologies have enhanced the study of mitochondrial function, particularly in human participants. The primary noninvasive method of measuring mitochondrial function has been magnetic resonance spectroscopy (MRS), and in particular the use of the kinetics of phosphocreatine (PCr) resynthesis after exercise as a direct assessment of mitochondrial capacity (30, 35) . However, MRS is a costly technique that requires large, expensive equipment and a high level of technical expertise, making measurement difficult. Near-infrared spectroscopy (NIRS) provides a noninvasive measure of muscle oxygenation (9, 10, 20, 31) . Commercially available NIRS devices typically provide information about the relative changes in oxygenated hemoglobin/myoglobin (O 2 Hb), deoxygenated hemoglobin/ myoglobin (HHb), and total hemoglobin or blood volume (tHb). Compared with MRS, these NIRS devices are much smaller, less expensive, portable, and easier to use, making them more practically useful for a clinical setting.
NIRS measurement of skeletal muscle oxygen consumption has been done previously using both venous and arterial occlusions (2, 18, 28, 36) . However, a number of researchers have suggested that during occlusions there is a blood volume change that could confound the slope measurements for oxygen consumption (4, 38) . Blood volume changes during occlusions can mask changes in the NIRS signals due to oxygen consumption. Some researchers have suggested that the deoxygenated hemoglobin/myoglobin (HHb) signal is less sensitive to blood volume changes (5, 17) . Motobe and colleagues (36) first described a method for measuring mitochondrial capacity using transient arterial occlusions and NIRS. In this study, participants performed shortduration handgrip exercise followed by repeated transient arterial occlusions to measure muscle oxygen consumption (mV O 2 ) (see Figure 1A of Ref. 36) . The repeated arterial occlusions were fit to a monoexponential curve and the time constant was calculated as a measure of muscle mitochondrial function (see Figure 1B of Ref. 36) . After a closer look at Figure 1A of Ref. 36 , there is an obvious blood volume (tHb) change during the arterial occlusions, which has an influence on the measurement of mV O 2 . In order for the arterial occlusion method of measuring mV O 2 to be valid, the NIRS signal should reflect a symmetrical change in O 2 Hb and HHb, and therefore no change in tHb (tHb ϭ O 2 Hb ϩ HHb). The dissociation of oxygen molecules from oxyhemoglobin/myoglobin, which supplies the oxygen required for oxidative phosphorylation, should be reflected in equal and opposite changes in the NIRS signals for O 2 Hb and HHb.
In this paper, we provide detailed methods for blood volume corrections, which allow for the reliable assessment of skeletal muscle mitochondrial function using NIRS. We have applied a blood volume correction to data from a variety of subjects including healthy college-aged participants (both recreationally active and sedentary) and clinical populations such as individuals with spinal cord injury. We also assessed the reliability and test-retest reproducibility of our measurements in young, healthy individuals.
MATERIALS AND METHODS

Subjects
Twenty-four subjects (14 male, 10 female) were tested in this study. Subjects were chosen to represent a wide variety of muscle oxidative capacity and included college-aged endurance-trained and sedentary, as well as four individuals with chronic spinal cord injury (SCI). Ten healthy, young subjects (6 male, 4 female) were tested on two separate days over a period of 1 wk to assess the reliability and reproducibility of our measurements. The study was conducted with the approval of the Institutional Review Board at the University of Georgia (Athens, GA), and all subjects gave written, informed consent before testing.
Experimental Protocol
Each subject was placed on a padded table, supine, with both legs extended (0°of flexion). The right foot was placed into a home-built isometric exercise device to limit motion artifact in the NIRS signal. The foot was strapped firmly to the exercise device using nonelastic Velcro straps proximal to the base of the fifth digit, and the knee was supported. The NIRS optode was placed at the level of the largest circumference of the muscle of interest (medial gastrocnemius or vastus lateralis) and secured with Velcro straps and biadhesive tape. Four aluminum foil electrodes attached to a Theratouch 4.7 stimulator (Rich-mar, Inola, OK) were placed on the skin, two proximal and two distal to the NIRS optode (Fig. 1) . A blood pressure cuff (Hokanson E20 cuff inflator; Bellevue, WA) was placed proximal to the NIRS optode.
Testing occurred on one visit to the laboratory. Subjects who participated in the reproducibility study were tested on a second occasion 3-7 days after the first session. Adipose tissue thickness (ATT) was measured at the site of the NIRS optode using B-mode ultrasound (LOGIQ e; GE HealthCare). Subjects were instructed not to consume caffeine or tobacco on the day of the test or to use alcohol or perform moderate or heavy physical activity for at least 24 h before the test.
The test protocol consisted of a baseline measurement of muscle oxygenation, followed by inflation of a blood pressure cuff (250 -300 mmHg) for the measurement of resting mV O2. To increase mV O2, 15 s of continuous electrical stimulation at 4 Hz was applied to the muscle. Previous studies have shown short-duration exercise produces similar initial rates of phosphocreatine resynthesis (40) . The current intensity was adjusted for each individual to produce twitch contractions at the maximal tolerable level. Pilot experiments suggested that small differences in stimulation level did not influence measurements of metabolic rate (data not reported). Immediately following the electrical stimulation, a series of 10 -18 brief (5-10 s) arterial occlusions were applied to measure the rate of recovery of mV O2 back to resting levels. To maximize our ability to measure the recovery of mV O2 while minimizing the discomfort to participants, the duration between arterial occlusions begins at 5 s and extends to 20 s by the end of the repeated occlusions (i.e., 5 s for cuffs 1-5, 10 s for cuffs 6 -10, 15-20 s for cuffs [11] [12] [13] [14] [15] . Finally, to normalize the NIRS signal, a 3-to 5-min arterial occlusion was applied to completely deoxygenate the tissue under the optode (i.e., 0% oxygenation), and the peak hyperemic response upon release of the cuff was used to indicate 100% oxygenation (Fig. 2) . A brief 5-s electrical stimulation period was performed prior to this 3-to 5-min arterial occlusion to increase metabolic rate, thereby minimizing the duration of the arterial occlusion and the discomfort imposed on the participants.
NIRS Device
NIRS signals were obtained using a continuous-wave NIRS device (Oxymon MK III, Artinis Medical Systems), which consists of two channels (2 equivalent pulsed light sources, 2 avalanche photodiode detectors, shielding from ambient light), and uses intensity-modulated light at a frequency of 1 MHz, and laser diodes at three wavelengths (905, 850, and 770 nm) corresponding to the absorption wavelengths of oxyhemoglobin (O 2Hb) and deoxyhemoglobin (HHb), with an autosensing power supply (ϳ40 W at 110 -240 V). The probe was set for two source-detector separation distances after measurement of adipose tissue thickness. The NIRS data were collected at 10 Hz.
Calculation of Muscle Oxygen Consumption
mV O2 was calculated as the slope of change in O2Hb and HHb during the arterial occlusion using simple linear regression. mV O2 was calculated in absolute units using a differential pathlength factor (DPF) of 4, as suggested by the manufacturer. mV O 2 was also expressed as a percentage of the ischemic calibration per unit time. This measurement was made at rest and repeated a number of times after exercise. The postexercise repeated measurements of mV O2 were fit to a monoexponential curve according to the formula below:
For this equation, y represents relative mV O2 during the arterial occlusion, End is the mV O2 immediately after the cessation of exercise, Delta is the change in mV O2 from rest to end exercise, and Tc is the fitting time constant.
Correction for Blood Volume
NIRS data were analyzed using custom-written routines for Matlab v. 7.13.0.564 (The Mathworks, Natick, MA). The calculation of a blood volume correction factor (␤) is based on the assumption that during an arterial occlusion, changes in O2Hb and HHb occur with a 1:1 ratio that represents mitochondrial oxygen consumption only (no arterial oxygen delivery or venous return of deoxygenated blood), thus making the area under the NIRS probe a closed system. The following equation can be used to conceptualize the blood volume change:
The change in NIRS signals (both HHb and O2Hb) during an arterial occlusion occurs due to a metabolic consumption of oxygen and a blood volume flux from the redistribution of heme between highpressure arteries/arterioles and low-pressure veins/venules. Therefore, accurate quantification of mV O2 requires either 1) no change in blood volume, or 2) the removal of blood volume change from the NIRS signal (i.e., mV O2 ϭ ⌬NIRSSignal Ϫ ⌬blood volume).
To correct NIRS signals for changes in blood volume, the blood change must be proportioned into oxygenated and deoxygenated sources. The equation below describes the calculation for this correction factor:
For this equation, ␤ is the blood volume correction factor, t represents time, O 2Hb is the oxygenated hemoglobin/myoglobin signal, and HHb is the deoxygenated hemoglobin/myoglobin signal. ␤ is a nondirectional factor that represents the proportionality of the blood volume change (values range from 0 to 1).
We used three approaches to determine ␤. Method 1. This method calculates a single ␤ for each arterial occlusion. The proportion of blood volume change attributed to the O 2Hb signal (␤) is calculated for each data point during an arterial occlusion. Next, the average ␤ is calculated for these data points. Once ␤ is obtained, it is applied to each individual data point using Eqs. 4 and 5 below. A single correction factor (␤) is applied to each individual data point over the course of the arterial occlusion.
Method 2. This method calculates a ␤ for each data point and can account for small changes in the proportionality of the blood volume change throughout a cuff. Each data point is then corrected using its corresponding ␤ according to Eqs. 4 and 5 below.
Method 3. This method calculates a global ␤ and assumes this value does not change throughout the test. This global ␤ is then applied to each arterial occlusion. To calculate ␤, a postprocessing correction was performed using an iterative least-squares error method for obtaining ␤ (using Nelder-Mead algorithm from Matlab's fminsearch function). This routine searches for the ␤ that minimized the sum of squared residuals (a residual being the difference between O 2Hb and HHb signals).
Once ␤ was defined, its application to the raw data is shown below:
HHb c ϭ HHb Ϫ (tHb ϫ ␤)
where O2Hbc and HHbc are the corrected oxygenated and deoxygenated hemoglobin/myoglobin signals, respectively; tHb if the arithmetic sum of the uncorrected O2Hb and HHb (the blood volume signal from the NIRS device); and ␤ is the blood volume correction factor. In Eq. 4, the raw O2Hb signal is corrected by subtracting the proportion of the blood volume [tHb ϫ (1 Ϫ ␤)] change attributed to O2Hb, thus producing a corrected O2Hb signal that represents the O2Hb signal minus the oxygenated blood volume change. Similarly, in Eq. 5, the raw HHb signal is corrected by subtracting the proportion of blood volume [tHb ϫ ␤] change attributed to HHb, thus producing a corrected HHb signal that represents the HHb signal minus the deoxygenated blood volume change.
Statistical Analysis
Data are presented as means Ϯ SD. Test-retest reliability was analyzed using coefficient of variation (CV) and intraclass correlation coefficients (ICC). Relative reliability is related to an individual maintaining his/her position within a sample for repeated measurements (1). We assess this type of reliability with the ICC, which indicates error in measurements as a proportion of the total variance in scores. ICC analysis was done using a downloadable spreadsheet (22) . The absolute reliability can be described as the degree to which repeated measurements vary for individuals. This was performed by calculating the CV for each subject, which is the SD of measurements recorded during both tests divided by the mean of the two tests. CV was expressed as a percentage. Statistical analyses were performed using SPSS 19.0 (IBM, Armonk, NY). The relationship between two variables was analyzed by least-squares regression analysis. Significance was accepted when P Ͻ 0.05.
RESULTS
All subjects were able to complete testing with no adverse events. The physical characteristics of participants are shown in Table 1 .
Blood Volume Correction
All data were analyzed using the three approaches described above for correction of the blood volume influence on the NIRS signal. There were no differences in resting, postexercise mV O 2 , or the recovery time constant using the three methods (P ϭ 0.39). All three methods produced similar results (R . While all three approaches produced similar results, correcting each data point (method 2) for its corresponding blood volume change was the most robust method and produced the most reliable results. Therefore, the remainder of the results was presented using method 2 (individualized ␤'s for each arterial occlusion). The application of the blood volume correction can be seen in Fig. 3 .
Without correcting for blood volume, there is an unequal change in the O 2 Hb and HHb signals during arterial occlusions in nearly all of the tests. We found no relationship between the recovery time constants for the O 2 Hb and HHb signals (P ϭ 0.78) without the blood volume correction (Fig. 4A) . When correcting for blood volume, there is a strong relationship between the O 2 Hb and HHb signals (P Ͻ 0.001) as shown in Fig. 4B . We did find the HHb signal was less susceptible to blood volume changes than the O 2 Hb signal in most cases. Because blood volume changes mask changes in oxygen consumption, the raw data, uncorrected for blood volume, were excluded from the remainder of the analysis. The average ␤ for all subjects and all test days was 0.52 Ϯ 0.21 (mean Ϯ SD). The blood volume correction (␤) was variable between individuals (CV ϭ 40.1%). However, ␤ was consistent between cuffs, and is not influenced by the metabolic rate of the tissue ( Fig. 5) . The mean CV between cuffs within a single test was 7.5% (range ϭ 0.3-26%). ␤ (within subjects) was more variable between test days 1 and 2 (CV ϭ 34%). Figure 5 shows the group average ␤ over the time for a resting arterial occlusion and the first end-exercise arterial occlusion. Although ␤ was variable between subjects, all individuals presented similar responses: no change in ␤ over the first 3 s followed by a gradual rise in ␤ during the final 1 s of occlusion (Fig. 5) . Within-subject ␤ from the resting occlusions was not statistically different from end-exercise ␤ for both test 1 and test 2 (P ϭ 0.414 and P ϭ 0.486, respectively). Resting ␤ was not statistically different for participants between test 1 and test 2 (P ϭ 0.823). Similarly, end-exercise ␤ was not statistically different for participants between test 1 and test 2 (P ϭ 0.805).
Reproducibility
The reproducibility of the NIRS measurements for resting mV O 2 and the end-exercise recovery of mV O 2 was investigated by testing 10 individuals on two separate occasions. All values for resting mV O 2 and the recovery of mV O 2 as well as the CV and ICC are shown in Table 2 .
Resting oxygen consumption. Resting oxygen consumption was measured by NIRS during an arterial occlusion (ϳ270 mmHg). Resting mV O 2 of all participants from day 1 and day 2 is shown in Fig. 6A . The mean within-subject CV for comparison between days was 2.4% (range 1-32%). There were no differences in resting oxygen consumption between the vastus lateralis and gastrocnemius muscles. We also compared the reliability and reproducibility of resting mV O 2 from a single arterial occlusion (ϳ30 s) with the average of three 10-s arterial occlusions (see Fig. 2 ). Averaging the three short resting cuffs decreased the within-subjects CV compared with the single cuff (CV ϭ 16% vs. 20%, for the average of 3 measurements and single measurement, respectively). This suggests that averaging three short arterial occlusions for the measurement of resting oxygen consumption produces a modest reduction in the variability. We saw no evidence for short repeated cuffs influencing resting metabolic rate.
End-exercise recovery of mV O 2 . End-exercise recovery of mV O 2 was measured by NIRS using brief (5-10 s) repeated arterial occlusions (ϳ270 mmHg). The time constant for the recovery of mV O 2 following electrical stimulation was 24.5 Ϯ 4.0 s (CV ϭ 16%) for day 1 and 22.1 Ϯ 2.1 s (CV ϭ 10%) for day 2. Recovery mV O 2 time constants of all participants from day 1 and day 2 are shown in Fig. 6B . Representative mV O 2 recovery curves from single subject for day 1 and day 2 are shown in Fig. 7 . The mean coefficient of variation between day 1 and day 2 was 10.6% ( Table 2) .
Influence of Depth
All NIRS testing was performed using two interoptode distances ranging from 3 to 4.5 cm. We compared resting mV O 2 measured at the shallow vs. deep NIRS signals and found good agreement between channels (r ϭ 0.91, P Ͻ 0.001) only when values were expressed as a percentage of the ischemic calibration. Using a differential pathlength factor (DPF) of 4, as recommended by the manufacturer, the relationship between shallow and deep penetration depths is weaker but still significant (r ϭ 0.68, P Ͻ 0.001). Figure 8 illustrates the agreement between penetration depths for the corrected recovery time constants. There were no significant differences in mV O 2 between penetration depths (P ϭ 0.21).
Effects of ATT on mV O 2
ATT was 6.0 Ϯ 1.6 mm on top of the medial gastrocnemius and 8.0 Ϯ 2.8 mm on top of the vastus lateralis muscle. ATT ranged from 3.3 to 12.0 mm in our participants. Resting mV O 2 was expressed two ways: using the recommended DPF of 4 to calculate absolute concentration changes and as a percentage of the ischemic calibration. The influence of ATT on mV O 2 for both methods is shown in Fig. 9 . There was a significant relationship between ATT and mV O 2 (r ϭ 0.41, P ϭ 0.026) calculated using the DPF method (Fig. 9A) . This relationship was no longer existent (r ϭ 0.006, P ϭ 0.668) when expressing resting mV O 2 as a percentage of the ischemic calibration (Fig. 9B) .
DISCUSSION
The primary finding of this study was the demonstration of methods to correct NIRS signals to account for changes in blood volume. The three different methods of blood volume correction resulted in consistent and reliable NIRS-based signals of skeletal muscle O 2 Hb and HHb during arterial occlusion measurements of oxidative metabolism. The appearance of blood volume changes in the NIRS signal, even with arterial and venous occlusion, has been reported by others (5, 8, 13, 17, 25) . The data from our raw, uncorrected signals support these volume effects. Our data also support the idea that the HHb signal is less susceptible to changes in blood volume (17) . While less influenced by blood volume shifts with occlusion, the uncorrected HHb signal resulted in recovery time constants that were twice as variable when compared with the blood volume-corrected HHb time constants. This suggests that the blood volume correction is needed to accurately detect oxygen consumption measurements for all the signals coming from the NIRS devices.
The exact cause of blood volume changes during arterial occlusions is currently unknown. Blood volume changes could be attributed to movement of heme concentrations from larger vessels (undetectable by NIRS) to microvascular beds detected Values are expressed as means Ϯ SD. Resting muscle oxygen consumption (mV O2) is expressed as a percentage of the ischemic calibration per second. The end-exercise recovery of mV O2 is expressed as the time constant (Tc) of the exponential fit. NIRS, near-infrared spectroscopy; CV, coefficient of variation; ICC, intraclass correlation coefficient; 95% CI, 95% lower and upper confidence intervals. by NIRS (31) . Since the NIRS probe is measuring distally to the arterial occlusion in the vascular tree, there is still a redistribution of heme under the NIRS probe between the high-pressure arterial and low-pressure venous systems. The blood volume correction factor (␤) was consistent between cuffs and was not influenced by the metabolic rate of the tissue. While the correction factor value was variable between subjects, all subjects had similar changes in ␤ over time. The ␤ did not change over the first 3 s of arterial occlusion (where the slope measurements for oxygen consumption were made), followed by a slight increase during the final 1-2 s of the occlusion. In most cases seen in this study the proportion of heme was primarily oxygenated heme, suggesting the influx of detectable signal was coming from the arterial side of the vascular tree. The effect of correcting NIRS signals for blood volume changes on measurements of oxygen consumption varies depending on both the magnitude and composition of the blood volume change. In most cases, the uncorrected data have large blood volume changes, primarily oxygenated heme, compared with the change due to metabolism. Therefore removing the blood volume change reverses the direction of the O 2 Hb signal during the arterial occlusions, thus allowing for the measurement of oxygen consumption. In some cases, the blood volume change is smaller than seen in Fig. 3 , and as a result correcting for blood volume has a small effect on the measured slopes. Because the correction factor to account for blood volume was more variable between participants and test sessions, we suggest that the correction method needs to be applied to each set of experiments. Furthermore, because the proportion of blood volume change can occur over time, we feel that correcting each data point in the O 2 Hb and HHb NIRS signals (method 2) produces the most accurate results.
In this study, resting oxygen consumption was more variable than the postexercise recovery of oxygen consumption. The variability of resting measurements of muscle metabolism in this study was consistent with previous studies. Van Beekvelt et al. (38) measured resting mV O 2 using venous and arterial occlusion methods, and reported similar between-subjects reliability (CV ϭ 33%) to our results (CV ϭ 30% and 39% for day 1 and day 2, respectively). Hamaoka et al. (18) reported resting muscle oxygen consumption as a percentage change in the O 2 Hb signal of five health male subjects to be 0.39%/s, which is slightly higher than our average resting mV O 2 of 0.28%/s.
In this study, we provide evidence that blood volumecorrected NIRS measurements for the recovery rate of mV O 2 after electrical stimulation exhibit good reliability. We reported a mean CV of 10% (range 1-22%) between day 1 and day 2. Our results are comparable to coefficients of variation reported for phosphocreatine recovery kinetics (27, 33, 40) . The time constant for recovery of mV O 2 measured in the gastrocnemius muscle also agrees with some reported values for phosphocreatine recovery (16, 21) , but is faster than other reports (15, 32, 33, 37) . One possible explanation for this difference is the individuals included in the reproducibility portion of this study were aerobically conditioned. Endurance-trained individuals have faster phosphocreatine recovery rates compared with their sedentary or less aerobically fit counterparts (26, 34) .
There are a number of potentially confounding factors for the quantification of continuous-wave NIRS signals including unknown optical pathlength, absorption, and scattering coefficients, as well as the influence of ATT. The development of frequency-and time-domain NIRS devices has enabled the continuous measurement of the pathlength and absorption/ scattering coefficients (3, 10 -12, 14, 41) . However, the influence of ATT on NIRS signals still exists even with more advanced NIRS devices (24) . As in the case of this study, and others using continuous-wave NIRS, ATT will influence the NIRS signal as the estimated depth of penetration is one-half the interoptode distance. The differential pathlength factor (DPF), which corrects for the scattering of photons in tissue, has been applied to continuous-wave NIRS for calculation of absolute concentration changes (6, 7) . With the large range of ATT of our participants (3.3-12.0 mm), we found a significant relationship between mV O 2 calculated using the DPF method and ATT, consistent with previous studies (39) . This suggests that the DPF may be different between individuals and/or locations of measurement within an individual, thereby supporting the need to measure DPF. However, previous studies have shown that ATT influences muscle deoxygenation kinetics even when accounting for differences in pathlength (24) . With the application of an ischemic calibration, the mV O 2 expressed as a percentage was no longer influenced by ATT (Fig. 9B) . The ischemic calibration scales NIRS signals according to the maximal "physiological" range. Thus our results support the use of a physiological ischemic calibration for the calculation of muscle oxygen saturation and consumption when comparing between individuals.
This study used two interoptode separation distances. This enabled us to compare measurements of muscle oxygen consumption between interoptode distances, to account for the potential effect of penetration depth on the metabolic measurements. The depth of muscle activation with electrical stimulation was unknown in this study, which could mean that some inactive tissue is contributing to NIRS signals. We did not find a significant influence of optode distance (sample depth) on muscle metabolic measurements, suggesting that the measurements of mitochondrial function can be compared between people with different ATT thicknesses and intramuscular fat percentages, as long as an ischemic calibration is performed.
In this study, the calculation of mV O 2 in absolute units was influenced by adipose tissue and skin overlying the muscle. Therefore, we chose to use an ischemic calibration to report our measurements of mV O 2 as a percentage change per unit time. This was a limitation in our study. To convert these relative units to absolute units of oxygen consumption (mM O 2 /time) assumptions would need to be made regarding muscle hematocrit, myoglobin concentration, and the contribution of myoglobin/hemoglobin to the NIRS signals. Some researchers have suggested hemoglobin to be the main contributor to the NIRS signal (8) . In contrast, Marcinek et al. (29) reported that myoglobin contributes ϳ80% to the NIRS signal using wavelength shift analysis. Future studies are needed to test these assumptions and calibrations to convert data from percent calibration to units of oxygen consumption (in mM O 2 ).
In conclusion, we measured mitochondrial capacity using NIRS and assessed the reliability and reproducibility of resting muscle oxygen consumption and the recovery rate of muscle oxygen consumption after exercise. A blood volume correction has been developed and applied to arterial occlusion measurements of oxygen consumption. Without correcting for blood volume changes, the metabolic exchange between O 2 Hb and HHb may be masked by blood changes under the NIRS probe. We demonstrate three methods for correcting blood volume changes. This study was performed using a continuous-wave NIRS system. The need to account for heme signals with different oxygen saturations moving into the NIRS-detectable tissue area should apply to time and frequency domain NIRS systems; however, future studies will be needed to test the method with those types of devices. In addition, more studies need to be conducted to explore differences in blood volume changes between individuals, and to accurately quantify NIRS measurements of oxygen consumption. Furthermore, comparisons also need to be made to established methods such as magnetic resonance spectroscopy.
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